Monday, 06 February 2023

 

 

LATEST NEWS SMVDU, Excise Deptt organise Mansar to Mahoregarh trek GDC Ramgarh elects College Presidium Pir Panjal Kabaddi League 2023 concludes at Doda Justice Tashi Rabstan inaugurates two day training for Legal Aid Defence Counsels PD&MD holds regional workshop on Sustainable Development Goals Lt Governor Manoj Sinha Inaugurates Special Governance Camps for Kashmiri Migrants Ben Affleck, Matt Damon-starrer 'Air' to get 'Super Bowl' ad, unprecedented release Bhagwant Mann flags off first batch of principals to Singapore for training Follow path shown by Guru Ravidass : Bhagwant Mann Babil Khan takes acting lessons from father Irrfan Khan's guru Kiara Advani arrives in Jaisalmer with Manish Malhotra; Siddharth Malhotra to follow in the evening Mithun Chakraborty To Sanjay Dutt: List Of Bollywood Celebrities Who Married Twice Or More Lt Governor Manoj Sinha and Union Sports Minister Anurag Singh Thakur launches 3rd Khelo India National Winter Games Anthem, Mascot and Jersey Lt Governor Manoj Sinha flags-off a batch of students from SKUAST-Jammu on an exposure cum training programme to Kansas State University, USA Big Breaking: Veteran Singer Vani Jayaram Passes Away At The Age Of 78 ILT20 : Former India keeper Naman Ojha to replace Dinesh Chandimal in Desert Vipers squad Sri Lanka will go a long way in this Women's T20 World Cup : Chamari Athapaththu Nathan Lyon needs to take pages from Erapalli Prasanna to show Australia the way in India : Greg Chappell Flu cases in Japan hit epidemic warning level Army soldier injured in landmine explosion in J&K along LoC Avalanche in Afghanistan kills 2, injures 3

 

From Vaccine to Vaccination

 Central Drugs Standard Control Organisation, CDSCO, Bharat Biotech, World Health Organization, WHO, Central Drugs Laboratory, Hyderabad, Coronavirus, COVID 19, Fight Against Corona, Covaxin, Covid-19 Vaccine, Oxygen, Oxygen Cylinders, SARS-CoV-2, Oxygen Plants, Oxygen Concentrator, Oxygen supply, Liquid Medical Oxygen

Web Admin

Web Admin

5 Dariya News

Hyderabad , 28 May 2021

 

The manufacturing, testing, release and distribution of vaccines is a complex and multifactorial process with hundreds of steps, requiring a diverse pool of human resources. For vaccines to result in actual vaccination of people, highly coordinated efforts are required from international supply chain, manufacturers, regulators and State and Central government agencies.Production scale-up of vaccines is a step-by-step process, involving several regulatory SOPs of GMP (Standard Operating Procedures of Good Manufacturing Practices). There is a four-month lag time for COVAXIN® to translate into actual vaccination.The timeline for manufacturing, testing and release for a batch of COVAXIN® is approximately 120 days, depending on the technology framework and regulatory guidelines to be met. Thus, production batches of COVAXIN® that were initiated during March this year will be ready for supply only during the month of June.Based on Central Drugs Standard Control Organisation(CDSCO) guidelines, all vaccines supplied in India are mandated by law to be submitted for testing and release to the Central Drugs Laboratory, Government of India. All batches of vaccines supplied to State and Central Governments are based on the allocation framework received from the Government of India.The timeline for vaccine supplies to reach the depots of the State and Central Governments from Bharat Biotech’s facilities is around two days. The vaccines received at these depots have to be further distributed by the State Governments to various districts within their respective states. This requires additional number of days. Pandemic vaccines are distributed by respective governments equitably across all sections of the population. Vaccines once available at the vaccination centers are then administered to recipients over a period of time, based on demand.

About Bharat Biotech

Bharat Biotech has established an excellent track record of innovation with more than 145 global patents, a wide product portfolio of more than 16 vaccines, 4 bio-therapeutics, registrations in more than 123 countries, and the World Health Organization (WHO) Pre-qualifications. Located in Genome Valley in Hyderabad, India, a hub for the global biotech industry, Bharat Biotech has built a world-class vaccine & bio-therapeutics, research & product development, Bio-Safety Level 3 manufacturing, and vaccine supply and distribution.Having delivered close to 5 billion doses of vaccines worldwide, Bharat Biotech continues to lead innovation and has developed vaccines for influenza H1N1, Rotavirus, Japanese Encephalitis (JENVAC®), Rabies, Chikungunya, Zika, Cholera, and the world’s first tetanus-toxoid conjugated vaccine for Typhoid. Bharat’s commitment to global social innovation programs and public-private partnerships resulted in introducing path-breaking WHO pre-qualified vaccines BIOPOLIO®, ROTAVAC®, and Typbar TCV® combatting polio, rotavirus, typhoid infections, respectively. The acquisition of Chiron Behring Vaccines, has positioned Bharat Biotech as the world's largest rabies vaccine manufacturer with Chirorab® and Indirab®.

 

Tags: Central Drugs Standard Control Organisation , CDSCO , Bharat Biotech , World Health Organization , WHO , Central Drugs Laboratory , Hyderabad , Coronavirus , COVID 19 , Fight Against Corona , Covaxin , Covid-19 Vaccine , Oxygen , Oxygen Cylinders , SARS-CoV-2 , Oxygen Plants , Oxygen Concentrator , Oxygen supply , Liquid Medical Oxygen

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2023 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD